Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000706349 | SCV000835393 | likely benign | Singleton-Merten syndrome 1; Aicardi-Goutieres syndrome 7 | 2023-11-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001759420 | SCV001986397 | uncertain significance | not provided | 2019-11-06 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV002493247 | SCV002794464 | uncertain significance | Singleton-Merten syndrome 1; Aicardi-Goutieres syndrome 7; Immunodeficiency 95 | 2022-04-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002534464 | SCV003747550 | uncertain significance | Inborn genetic diseases | 2021-07-13 | criteria provided, single submitter | clinical testing | The c.2788A>C (p.N930H) alteration is located in exon 14 (coding exon 14) of the IFIH1 gene. This alteration results from a A to C substitution at nucleotide position 2788, causing the asparagine (N) at amino acid position 930 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |